J
Jasper Therapeutics, Inc. (JSPR)
NCM – Real Time Price. Currency in USD
0.34
-0.10 (-22.99%)
At close: Jun 26, 2026, 4:00 PM EDT
0.35
+0.01 (2.64%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.34
-0.10 (-22.99%)
At close: Jun 26, 2026, 4:00 PM EDT
0.35
+0.01 (2.64%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $14.1M significantly exceed its total debt $757.0K, ensuring strong financial flexibility
Total current assets $20.3M exceed Total current liabilities $9.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$14.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.26 | 6.05 | 10 | |
| Quick ratio | 2.26 | 5.63 | 10 | |
| Debt to Equity | 0.22 | 0.30 | 8.0 | |
| Debt to Assets | 0.04 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -1M | -1M | -1M | -1M | -798K |
| Operating Income | -53M | -70M | -78M | -81M | -70M |
| Net Income | -38M | -64M | -71M | -76M | -56M |
| EBITDA | -52M | -69M | -76M | -79M | -69M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 82.86 | 5.5 |
| Next quarter | N/A | 71.76 | 5.5 |
| Current year | N/A | 71.93 | 5.5 |
| Next year | N/A | -18.69 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 87.1 | 87.5 | 33.47 | 10 |
| Y/Y | 999 | 94.47 | 97.16 | 36.31 | 10 |
| 3y average | 999 | -29.3 | 26.7 | -18.5 | 5.5 |
| 5y average | 999 | -21.52 | 35.45 | -36.35 | 5.5 |
| Weighted average score | 7.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |